ENCORE Borland-Groover Clinical Research
Jacksonville, Florida, United States
Medical clinic in Jacksonville, Florida
4800 Belfort Rd Suite 301, Jacksonville, FL 32256
About ENCORE Borland-Groover Clinical Research
"We are a member site of ENCORE Research Group, a premier clinical research organization that has conducted more than 2,500 clinical trials over 20 years and has worldwide recognition for providing patients access to cutting edge medical research. If you have a medical issue and want a research solution, or if you are a healthy volunteer, come visit our center and learn more. One of our experts will be happy to evaluate you."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Phathom Pharmaceuticals, Inc.
4
Shire
3
Celgene
2
Gilead Sciences
2
Medtronic - MITG
2
Axcella Health, Inc
1
Eli Lilly and Company
1
Ellodi Pharmaceuticals, LP
1
Enanta Pharmaceuticals, Inc
1
Finch Research and Development LLC.
1
Genfit
1
Clinical Trials at ENCORE Borland-Groover Clinical Research
During the past decade, ENCORE Borland-Groover Clinical Research conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 7 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 7 clinical trials were completed. i.e. 58.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease.
2017-12-21
2019-06-20
Completed
187
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis
2017-12-05
2020-10-06
Terminated
279
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
2018-02-27
2023-12-31
Active, not recruiting
557
An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis
2018-04-04
2021-07-01
Completed
366
A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)
2018-07-18
2029-04-25
Recruiting
960
Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA)
2018-12-13
2025-12-30
Recruiting
8,000
Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis
2019-10-28
2021-08-24
Completed
1,027
Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis
2019-12-20
2021-12-14
Terminated
19
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "ENCORE Borland-Groover Clinical Research" #1 sponsor was "Phathom Pharmaceuticals, Inc." with 4 trials, followed by "Shire" with 3 trials
sponsored, "Celgene" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Medtronic - MITG"
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "ENCORE Borland-Groover Clinical Research"
#1 collaborator was "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at ENCORE Borland-Groover Clinical Research
According to Clinical.Site data, the most researched conditions in "ENCORE Borland-Groover Clinical Research" are
"Ulcerative Colitis" (5 trials), "Eosinophilic Esophagitis" (3 trials), "Heartburn" (2 trials), "Non-Erosive Gastro-Esophageal Reflux Disease" (2 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "ENCORE Borland-Groover Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at ENCORE Borland-Groover Clinical Research
Most popular intervention types in "ENCORE Borland-Groover Clinical Research" are "Drug" (17 trials), "Other" (3 trials), "Biological" (1 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Vonoprazan" (4 trials), "CC-93538" (2 trials), "Lansoprazole" (2 trials) and "Ontamalimab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at ENCORE Borland-Groover Clinical Research
The vast majority of trials in "ENCORE Borland-Groover Clinical Research" are
21 trials for "All" genders.
Clinical Trials Status at ENCORE Borland-Groover Clinical Research
Currently, there are NaN active trials in "ENCORE Borland-Groover Clinical Research".
undefined are not yet recruiting,
8 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in ENCORE Borland-Groover Clinical Research,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in ENCORE Borland-Groover Clinical Research, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".